Edition:
United States

Second Sight Medical Products Inc (EYES.OQ)

EYES.OQ on NASDAQ Stock Exchange Capital Market

1.57USD
19 Oct 2018
Change (% chg)

$-0.05 (-3.09%)
Prev Close
$1.62
Open
$1.63
Day's High
$1.63
Day's Low
$1.56
Volume
25,914
Avg. Vol
35,620
52-wk High
$2.58
52-wk Low
$1.05

Chart for

About

Second Sight Medical Products, Inc. is engaged in developing, manufacturing and marketing prosthetic devices that restore vision to blind individuals. The Company's product, the Argus II System, treats outer retinal degenerations, such as retinitis pigmentosa (RP). The Argus II System provides an artificial form of vision that... (more)

Overall

Beta: 3.09
Market Cap(Mil.): $107.32
Shares Outstanding(Mil.): 67.07
Dividend: --
Yield (%): --

Financials

  EYES.OQ Industry Sector
P/E (TTM): -- 38.68 32.14
EPS (TTM): -0.54 -- --
ROI: -251.23 13.89 12.83
ROE: -251.23 16.74 14.95

BRIEF-Second Sight Reports Q1 Loss Per Share $0.17

* Q1 NON-GAAP LOSS PER SHARE $0.14 EXCLUDING ITEMS Source text for Eikon: Further company coverage:

May 10 2018

BRIEF-Second Sight Completes $10 Mln Private Placement Of Common Stock With Chairman Of Board Of Directors

* SECOND SIGHT COMPLETES $10 MILLION PRIVATE PLACEMENT OF COMMON STOCK WITH GREGG WILLIAMS, CHAIRMAN OF THE BOARD OF DIRECTORS Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

May 07 2018

Earnings vs. Estimates